Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!
EMD-35623
SARS-CoV-2 XBB.1 spike glycoprotein (closed-2 state)
EMD-35623
Single-particle2.51 Å
Deposition: 13/03/2023Map released: 24/05/2023
Last modified: 30/10/2024
Sample Organism:
Severe acute respiratory syndrome coronavirus 2
Sample: SARS-COV-2 XBB.1 spike glycoprotein
Fitted models: 8iot
Deposition Authors: Anraku Y
,
Kita S
,
Yajima H,
Sasaki J,
Sasaki-Tabata K,
Maenaka K,
Hashiguchi T
Sample: SARS-COV-2 XBB.1 spike glycoprotein
Fitted models: 8iot
Deposition Authors: Anraku Y
,
Kita S
,
Yajima H,
Sasaki J,
Sasaki-Tabata K,
Maenaka K,
Hashiguchi T
Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants.
Tamura T
,
Ito J
,
Uriu K,
Zahradnik J
,
Kida I
,
Anraku Y
,
Nasser H
,
Shofa M,
Oda Y,
Lytras S
,
Nao N,
Itakura Y
,
Deguchi S,
Suzuki R,
Wang L
,
Begum MM,
Kita S
,
Yajima H,
Sasaki J,
Sasaki-Tabata K,
Shimizu R,
Tsuda M
,
Kosugi Y,
Fujita S
,
Pan L,
Sauter D
,
Yoshimatsu K
,
Suzuki S
,
Asakura H,
Nagashima M,
Sadamasu K,
Yoshimura K,
Yamamoto Y
,
Nagamoto T,
Schreiber G
,
Maenaka K,
Hashiguchi T
,
Ikeda T
,
Fukuhara T
,
Saito A
,
Tanaka S,
Matsuno K
,
Takayama K
,
Sato K
(2023) Nat Commun , 14 , 2800 - 2800
,
Ito J
,
Uriu K,
Zahradnik J
,
Kida I
,
Anraku Y
,
Nasser H
,
Shofa M,
Oda Y,
Lytras S
,
Nao N,
Itakura Y
,
Deguchi S,
Suzuki R,
Wang L
,
Begum MM,
Kita S
,
Yajima H,
Sasaki J,
Sasaki-Tabata K,
Shimizu R,
Tsuda M
,
Kosugi Y,
Fujita S
,
Pan L,
Sauter D
,
Yoshimatsu K
,
Suzuki S
,
Asakura H,
Nagashima M,
Sadamasu K,
Yoshimura K,
Yamamoto Y
,
Nagamoto T,
Schreiber G
,
Maenaka K,
Hashiguchi T
,
Ikeda T
,
Fukuhara T
,
Saito A
,
Tanaka S,
Matsuno K
,
Takayama K
,
Sato K
(2023) Nat Commun , 14 , 2800 - 2800
Grant Support:
- Japan Agency for Medical Research and Development (AMED): JP21am0101093 (Japan)
- Japan Agency for Medical Research and Development (AMED): JP22ama121037 (Japan)
- Japan Science and Technology: JPMJCR20H8 (Japan)
- Japan Society for the Promotion of Science (JSPS): JPJSCCA20190008 (Japan)
- Japan Society for the Promotion of Science (JSPS): 20H05773 (Japan)
- Japan Society for the Promotion of Science (JSPS): JP20H05873 (Japan)
